anti-SARS2-CoV-2 spike protein antibody (Walter and Eliza Hall Institute of Medical Research)

N/A

Report date: 2025/01/26 19:31:45

Base Information

Drug Nameanti-SARS2-CoV-2 spike protein antibody (Walter and Eliza Hall Institute of Medical Research)
Drug Alias Namespike protein neutralizing antibody (Walter & Eliza Hall Institute)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A